Actively Recruiting
Project 3: ACHIEVE- CHD
Led by University Hospitals Cleveland Medical Center · Updated on 2025-07-14
500
Participants Needed
1
Research Sites
228 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region) Center (IRB 100221MP2A), the purpose of which is to reduce cardiometabolic health disparities and downstream Black-White lifespan inequality in two cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center will involve three separate but related projects that aim to mitigate health disparities in risk factor control for three chronic conditions, hypertension (HTN, Project 1), heart failure (HF, Project 2) and coronary heart disease (CHD, Project 3), which drive downstream lifespan inequality. All three projects will involve the use of Community Health Workers (CHWs) to deliver an evidence-based practice intervention program called PAL2. All three projects will also utilize the PAL2 Implementation Intervention (PAL2-II), which is a set of structured training and evaluation strategies designed to optimize CHW competence and adherence (i.e., fidelity) to the PAL2 intervention program. The present study is Project 3 of the ACHIEVE GREATER Center.
CONDITIONS
Official Title
Project 3: ACHIEVE- CHD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 40 to 75 years of age
- Self-identified as Black or African American
- Residence in the Cleveland Metro Area
- At least two risk factors including BMI over 30 mg/dL, history of smoking, elevated blood pressure (SBP >140 or DBP >80 mmHg), HbA1c ≥5.7%, or LDL ≥130
- Able to complete a coronary artery calcium score test
- Willing and able to provide consent
- Willing to receive care from a University Hospitals provider
- Currently insured for standard care procedures
You will not qualify if you...
- Established documented cardiovascular disease such as coronary artery disease, peripheral artery disease, myocardial infarction, or stroke
- Systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥110 mmHg
- Lung disease requiring supplemental oxygen therapy
- Currently receiving treatment for cancer
- Pregnant or nursing mothers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States, 44106
Actively Recruiting
Research Team
S
Sanjay Rajagopalan, MD
CONTACT
H
Heidi Osborne
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here